Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis — Stella

Home/Status Epilepticus/

View on ClinicalTrials.gov

Recruiting

Back to Status Epilepticus trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Hôpital de la Pitié Salpêtrière, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~400 participants

Started

November 2020

Primary completion

June 2027

Age range

2 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.